I am currently CEO of Bioscript Group, a scientific communications partner to the life sciences sector, which is backed by Sovereign Capital. I’m also a Non-exec Director for both Opiant Pharmaceuticals Inc and the Royal National Orthopaedic Hospital.
I have experience directing organisations throughout the stages of private equity ownership, most recently as CEO of CHS Healthcare, where I oversaw a period of rapid growth through to an acquisition by Acacium Group in 2021, delivering a successful exit for BGF.
I enjoy sharing my experience with PepTalks members with regards to succeeding an entrepreneurial Founder, professionalising businesses, integrating acquisitions and delivering a private equity backed trade sale.